Accordingly exogenous supplementation of IL-2 temporarily restored CD25 expression in Treg and the homeostatic balance between Treg and Tcon, and was capable to reduce disease activity in lupus-prone mice and also in SLE patients with active disease [14,15,16,17,18]. This evidence concerns the gene IL2 and systemic lupus erythematosus.